Tcg Crossover Management, LLC has filed its 13F form on May 15, 2024 for Q1 2024 where it was disclosed a total value porftolio of $950 Million distributed in 33 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Dyne Therapeutics, Inc. with a value of $75.2M, Astria Therapeutics, Inc. with a value of $74.3M, Silence Therapeutics PLC with a value of $71.2M, Aerovate Therapeutics, Inc. with a value of $65.1M, and Inhibrx, Inc. with a value of $61.2M.
Examining the 13F form we can see an increase of $227M in the current position value, from $723M to 950M.
Tcg Crossover Management, LLC is based out at Palo Alto, CA
Below you can find more details about Tcg Crossover Management, LLC portfolio as well as his latest detailed transactions.